Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.292
-0.005 (-1.75%)
Nov 4, 2024, 4:00 PM EST - Market closed
Cara Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Hold
Price Target
$1.00
Upside
+242.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $10 → $1 | Strong Buy → Hold | Downgrades | $10 → $1 | +242.70% | Jun 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 13, 2024 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,613.50% | May 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3.6 | Strong Buy | Reiterates | $3.6 | +1,133.72% | May 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,613.50% | May 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,613.50% | Apr 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,613.50% | Mar 28, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +3,327.00% | Mar 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,613.50% | Mar 5, 2024 |
| Needham | Needham | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +1,613.50% | Jan 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $2.5 | Strong Buy | Maintains | $7 → $2.5 | +756.75% | Dec 19, 2023 |
| Needham | Needham | Strong Buy Maintains $22 → $6 | Strong Buy | Maintains | $22 → $6 | +1,956.20% | Dec 18, 2023 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $12 → $1 | Buy → Hold | Downgrades | $12 → $1 | +242.70% | Nov 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $7 | Strong Buy | Maintains | $15 → $7 | +2,298.90% | Oct 19, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | +4,012.41% | Aug 8, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.